{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:13:50Z","timestamp":1777396430430,"version":"3.51.4"},"reference-count":35,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,9,12]]},"abstract":"<jats:p>Numerous preclinical and human tissue studies implicate the protein phosphatase calcineurin (CN) as a pathophysiologic mechanism in Alzheimer\u2019s disease (AD) and other neurodegenerative conditions. Using public electronic records of tens of thousands of individuals across the United States, Silva et al. (2023) show that use of the FDA-approved CN inhibitor, tacrolimus (for purposes of immunosuppression) is also associated with reduced prevalence of dementia-related symptoms. Notably, the study controls for age, sex, and race as well as multiple risk factors for AD. The results suggest that tacrolimus, and possibly other immunosuppressants could be repurposed for the treatment of AD-related dementia.<\/jats:p>","DOI":"10.3233\/jad-230780","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T11:32:54Z","timestamp":1693308774000},"page":"599-602","source":"Crossref","is-referenced-by-count":3,"title":["Is It Time to Repurpose Calcineurin Inhibitors for the Treatment of Cognitive Impairment and Dementia?"],"prefix":"10.1177","volume":"95","author":[{"given":"Christopher M.","family":"Norris","sequence":"first","affiliation":[{"name":"Sanders-Brown Center on Aging, University of Kentucky College of Medicine, Lexington, KY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-230780_ref1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1101\/lm.027201.112","article-title":"Neural functions of calcineurin in synaptic plasticity and memory","volume":"19","author":"Baumgartel","year":"2012","journal-title":"Learn Mem"},{"key":"10.3233\/JAD-230780_ref2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fnagi.2018.00199","article-title":"Ca(2+), astrocyte activation and calcineurin\/NFAT signaling in age-related neurodegenerative diseases","volume":"10","author":"Sompol","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-230780_ref3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2174\/157015911798376316","article-title":"A role for calcineurin in Alzheimer\u2019s disease","volume":"9","author":"Reese","year":"2011","journal-title":"Curr Neuropharmacol"},{"key":"10.3233\/JAD-230780_ref4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12974-014-0158-7","article-title":"Calcineurin and glial signaling: Neuroinflammation and beyond","volume":"11","author":"Furman","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-230780_ref5","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s11064-022-03744-4","article-title":"Calcineurin signalling in astrocytes: From pathology to physiology and control of neuronal functions","volume":"48","author":"Lim","year":"2023","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-230780_ref6","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.bbrc.2016.09.053","article-title":"Dysregulation of neuronal calcium homeostasis in Alzheimer\u2019s disease - A therapeutic opportunity?","volume":"483","author":"Popugaeva","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-230780_ref7","doi-asserted-by":"crossref","first-page":"12957","DOI":"10.1523\/JNEUROSCI.1064-09.2009","article-title":"Cognitive decline in Alzheimer\u2019s disease is associated with selective changes in calcineurin\/NFAT signaling","volume":"29","author":"Abdul","year":"2009","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-230780_ref8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1474-9726.2010.00645.x","article-title":"Proteolysis of calcineurin is increased in human hippocampus during mild cognitive impairment and is stimulated by oligomeric Abeta in primary cell culture","volume":"10","author":"Mohmmad Abdul","year":"2011","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-230780_ref9","doi-asserted-by":"crossref","first-page":"37755","DOI":"10.1074\/jbc.M507475200","article-title":"Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain","volume":"280","author":"Liu","year":"2005","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-230780_ref10","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1523\/JNEUROSCI.4456-09.2010","article-title":"Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation","volume":"30","author":"Wu","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-230780_ref11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.nbd.2010.11.014","article-title":"Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice","volume":"41","author":"Rozkalne","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-230780_ref12","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1523\/JNEUROSCI.6439-11.2012","article-title":"Inhibition of the NFAT pathway alleviates amyloid beta neurotoxicity in a mouse model of Alzheimer\u2019s disease","volume":"32","author":"Hudry","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-230780_ref13","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1002\/jnr.22445","article-title":"Amyloid-beta oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice","volume":"88","author":"Dineley","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.3233\/JAD-230780_ref14","doi-asserted-by":"crossref","first-page":"16129","DOI":"10.1523\/JNEUROSCI.2323-12.2012","article-title":"Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer\u2019s disease","volume":"32","author":"Furman","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-230780_ref15","doi-asserted-by":"crossref","first-page":"e13416","DOI":"10.1111\/acel.13416","article-title":"Q134R: Small chemical compound with NFAT inhibitory properties improves behavioral performance and synapse function in mouse models of amyloid pathology","volume":"20","author":"Sompol","year":"2021","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-230780_ref16","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1523\/JNEUROSCI.0877-17.2017","article-title":"Calcineurin\/NFAT signaling in activated astrocytes drives network hyperexcitability in Abeta-bearing mice","volume":"37","author":"Sompol","year":"2017","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-230780_ref17","doi-asserted-by":"crossref","first-page":"9641","DOI":"10.1523\/JNEUROSCI.0828-10.2010","article-title":"Microglial phenotype is regulated by activity of the transcription factor, NFAT (nuclear factor of activated T cells)","volume":"30","author":"Nagamoto-Combs","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-230780_ref18","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1523\/JNEUROSCI.1333-22.2023","article-title":"Targeting Astrocyte signaling alleviates cerebrovascular and synaptic function deficits in a diet-based mouse model of small cerebral vessel disease","volume":"43","author":"Sompol","year":"2023","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-230780_ref19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.3233\/JAD-230780_ref20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature09706","article-title":"Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB","volume":"470","author":"Mair","year":"2011","journal-title":"Nature"},{"key":"10.3233\/JAD-230780_ref21","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1523\/JNEUROSCI.0361-21.2021","article-title":"Tacrolimus protects against age-associated microstructural changes in the beagle brain","volume":"41","author":"Radhakrishnan","year":"2021","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-230780_ref22","doi-asserted-by":"crossref","first-page":"e069099","DOI":"10.1002\/alz.069099","article-title":"Effect of calcineurin inhibitors on cognition in a canine model of Alzheimer\u2019s disease","volume":"18","author":"Sordo","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230780_ref23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0092-8674(00)80896-X","article-title":"Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin","volume":"92","author":"Winder","year":"1998","journal-title":"Cell"},{"key":"10.3233\/JAD-230780_ref24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0092-8674(00)80897-1","article-title":"Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory","volume":"92","author":"Mansuy","year":"1998","journal-title":"Cell"},{"key":"10.3233\/JAD-230780_ref25","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1523\/JNEUROSCI.1002-07.2007","article-title":"Calcineurin in reactive astrocytes plays a key role in the interplay between proinflammatory and anti-inflammatory signals","volume":"27","author":"Fernandez","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-230780_ref26","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1523\/JNEUROSCI.0365-05.2005","article-title":"Calcineurin triggers reactive\/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer\u2019s models","volume":"25","author":"Norris","year":"2005","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-230780_ref27","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.bbadis.2016.05.007","article-title":"Calcineurin proteolysis in astrocytes: Implications for impaired synaptic function","volume":"1862","author":"Pleiss","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-230780_ref28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bbr.2008.12.034","article-title":"Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition","volume":"200","author":"Taglialatela","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-230780_ref29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.nlm.2007.03.010","article-title":"Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice","volume":"88","author":"Dineley","year":"2007","journal-title":"Neurobiol Learn Mem"},{"key":"10.3233\/JAD-230780_ref30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/JAD-150065","article-title":"Reduced incidence of dementia in solid organ transplant patients treated with calcineurin inhibitors","volume":"47","author":"Taglialatela","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230780_ref31","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3233\/JAD-230526","article-title":"Reduced prevalence of dementia in patients prescribed tacrolimus, sirolimus, or cyclosporine","volume":"95","author":"Silva","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230780_ref32","first-page":"1946","article-title":"Pharmacokinetic animal PET study of FK506 as a potent neuroprotective agent","volume":"45","author":"Murakami","year":"2004","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-230780_ref33","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/j.1471-4159.1990.tb03128.x","article-title":"Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A","volume":"55","author":"Begley","year":"1990","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-230780_ref34","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/jnr.23011","article-title":"Mammalian target of rapamycin: A valid theraeutic target through the autophagy pathway for Alzheimer\u2019s disease?","volume":"90","author":"Cai","year":"2012","journal-title":"J Neurosci Res"},{"key":"10.3233\/JAD-230780_ref35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/aor.13551","article-title":"Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity","volume":"44","author":"Bentata","year":"2020","journal-title":"Artif Organs"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-230780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:24Z","timestamp":1777370904000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-230780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":35,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-230780","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]}}}